Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk

This publication has 32 references indexed in Scilit:

• Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease
  Journal of the American College of Cardiology, 2003
• Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease
  Journal of the American College of Cardiology, 2003
• Antioxidant Vitamins and Lipid Therapy
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
• Common Hepatic Lipase Gene Promoter Variant Determines Clinical Response to Intensive Lipid-Lowering Treatment
  Circulation, 2001
• Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction
  Genetic Epidemiology, 2000
• Cholesteryl ester transfer protein gene effect on CETP activity and plasma high‐density lipoprotein in European populations
  European Journal of Clinical Investigation, 1999
• Common Variants in the Promoter of the Hepatic Lipase Gene Are Associated With Lower Levels of Hepatic Lipase Activity, Buoyant LDL, and Higher HDL₂Cholesterol
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.
  Journal of Clinical Investigation, 1998
• Common C-to-T Substitution at Position −480 of the Hepatic Lipase Promoter Associated With a Lowered Lipase Activity in Coronary Artery Disease Patients
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Heterogeneity at theCETPGene Locus
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997